News

StockWatch: Investors, Analysts Debate Background of New Illumina CEO

2023-09-12

In announcing Jacob Thaysen, PhD, as its new CEO on Tuesday, Illumina (ILMN) trumpeted his “extensive background and experience” in genomics, life sciences, and technology after more than a decade at Agilent Technologies and five years before that at Dako, the Danish cancer diagnostics developer which Agilent acquired in 2012. Thaysen will become Illumina’s CEO on September 25 after five years as Agilent’s senior vice president and president of its largest division, the Life Sciences......

MORE DETAILS

AACR-Lung Cancer Patients Face Worse Survival After Wildfire Exposure

2023-09-12

Researchers find that lung cancer patients recovering from surgery are especially vulnerable to the health hazards of wildfires even up to a year later.

MORE DETAILS

AACR 2023-September 8: The Week in Cancer News

2023-09-12

AACR Research shows an increase in late-stage prostate cancer diagnosis, and many non-English speakers don’t make it past helplines to access services.

MORE DETAILS

AACC Annual Meeting & Clinical Lab Expo 2023

2023-09-01

AACC is the annual leading event for laboratory medicine in the world. The Annual Meeting & Clinical Lab Expo is where innovations in clinical testing field and patient care are introduced to the healthcare world.Attendees will have the chance to learn about the changes in the sector and get benefit from more than 400 educational sessions. On the same way, they will discover cutting edge diagnostic technology and connect with global experts related to clinical chemistry.

MORE DETAILS

Abcam agrees $5.7bn sale to Danaher after 20 potential acquirers pitched in

2023-09-01

US corporation Danaher, quoted on Wall Street, has agreed to buy Cambridge life sciences tool specialist Abcam for around $5.7 billion – just weeks after co-founder Jonathan Milner called for an EGM to take over as executive chairman alleging that Abcam’s value was not being maximised.

MORE DETAILS

Go to page

About us: Our products include chemicals and biologicals for scientific research in biology (cell biology, molecular biology and protein biology research), vaccine generation and production, biomedical diagnosis. and veterinary hygiene. Our company alos provides high quality products, optimal advanced technology solutions to help customers accelerate the progress of transitioning their research products to manufacturing or serving the medical care.
We distribute reagents, consumables and laboratory equipment for molecular biology, biotechnology, biochemistry, molecular diagnostics, quality control, tissue culture, forensic as well as genomics, proteomics and in vitro fertilization centers. We represent companies of recognized trajectory and, together with them, we are committed to the development and productive efficiency in science.

View More

Contact Us: 6TH FLOOR,TOWER 1, NO.8 CHANGXIANG ROAD,SHANGHAI, PR.CHINA; beyondbiotech@126.com; Phone:+86-021-31430785 Mob: +86-15901864269 Whatsapp:+86 15901864269

Newsletter: Lorem ipsum dolor si consectetur adipisicing elit, sed eiusmotempor incididunt ut labore et

Follow Us